Security key
54948X109
Lucid Diagnostics Inc. - Common Stock, par value $0.001 per share (LUCD)
CUSIP: 54948X109
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 141,152,375
- Total 13F shares
- 1,863,743
- Share change
- +95,239
- Total reported value
- $2,590,935
- Price per share
- $1.39
- Number of holders
- 16
- Value change
- +$131,895
- Number of buys
- 6
- Number of sells
- 7
Report period
Q2 2023
Institutions
16
Top holders
10
LUCD full security history
Newer quarter: Q3 2023
Previous quarter: Q1 2023
Lucid Diagnostics Inc. SEC filings
Lucid Diagnostics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 54948X109
Recent filing periods:
Top shareholders of LUCD - Lucid Diagnostics Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| LUMINUS MANAGEMENT LLC |
13F
|
Company |
0.61%
|
855,300
|
$1,197,420 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.23%
|
319,433
|
$447,206 | — | 31 Mar 2023 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
0.19%
|
261,664
|
$376,796 | — | 31 Mar 2023 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.1%
|
135,000
|
$189,000 | — | 31 Mar 2023 | |
| Verition Fund Management LLC |
13F
|
Company |
0.04%
|
50,462
|
$70,647 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
41,543
|
$58,160 | — | 31 Mar 2023 | |
| Geneos Wealth Management Inc. |
13F
|
Company |
0.02%
|
33,850
|
$47,390 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.01%
|
18,856
|
$26,398 | — | 31 Mar 2023 | |
| Virtu Financial LLC |
13F
|
Company |
0.01%
|
15,545
|
$22,000 | — | 31 Mar 2023 | |
| LPL Financial LLC |
13F
|
Company |
0.01%
|
14,400
|
$20,160 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.01%
|
10,521
|
$14,729 | — | 31 Mar 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
3,093
|
$4,000 | — | 31 Mar 2023 | |
| UBS Group AG |
13F
|
Company |
0%
|
2,558
|
$3,581 | — | 31 Mar 2023 | |
| CWM, LLC |
13F
|
Company |
0%
|
1,920
|
$3,000 | — | 31 Mar 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
2,000
|
$2,800 | — | 31 Mar 2023 | |
| Belpointe Asset Management LLC |
13F
|
Company |
0%
|
1,500
|
$2,100 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
800
|
$1,120 | — | 31 Mar 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
59
|
$83 | — | 31 Mar 2023 | |
| Aster Angagaw |
3/4/5
|
Director |
—
class O/S missing
|
59,000
|
— | — | 18 Feb 2022 |
Institutional Holders of Lucid Diagnostics Inc. - Common Stock, par value $0.001 per share (LUCD) as of Q2 2023
As of 30 Jun 2023,
Lucid Diagnostics Inc. - Common Stock, par value $0.001 per share (LUCD) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,863,743 shares.
The largest 10 holders included
LUMINUS MANAGEMENT LLC, VANGUARD GROUP INC, Nantahala Capital Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, Verition Fund Management LLC, Geneos Wealth Management Inc., BlackRock Inc., and LPL Financial LLC.
This page lists
16
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
18
Q2 2023 holders
16
Holder diff
-2
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.